CervoMed
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CervoMed generated cash of -$7,449,847, which is less than the previous year. Cash used in financing activities reached the amount of $11,149,114 last year. Net change in cash is therefore $3,699,267.

Cash Flow

CervoMed Inc. (NASDAQ:CRVO): Cash Flow
2015 -5.18M 2.45M 2.38M
2017 -12.33M -447.82K 20.12M
2019 -9.85M 0 16.04M
2022 -2.57M -12.23M 0
2023 -7.44M 0 11.14M

CRVO Cash Flow Statement (2015 – 2023)

2023 2022 2019 2017 2015
Cash at beginning of period
4.09M37.31M7.99M1.55M2.33M
Operating activities
Net income
-2.17M-5.80M-11.79M-1.36M-6.71M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
0097.91K67.98K8.26K
Stock-based compensation expense
407.63K333.83K00594.17K
Deferred income tax benefit 407.63K333.83K00594.17K
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
565.16K79.15K567.66K-1.66M647.58K
Cash generated by operating activities
-7.44M-2.57M-9.85M-12.33M-5.18M
Investing activities
Purchases Of Investments
0-37.98M0-10M0
Investments In Property Plant And Equipment
-300-447.82K-40.29K
Acquisitions Net
0000-250K
Cash generated by investing activities
0-12.23M0-447.82K2.45M
Financing activities
Common Stock Issued
810K012.31M22.00M0
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
000-1.88M2.40M
Cash used in financing activities
11.14M016.04M20.12M2.38M
Net Change In Cash
3.69M-33.21M6.18M7.34M-339.32K
Cash at end of period
7.79M4.09M14.17M8.89M1.99M
Data source